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Uso de medicamentos e fatores associados em adultos residentes 
em Campinas, São Paulo, Brasil: diferenças entre homens e mulheres
resumo  O objetivo do presente estudo foi veri-
ficar os fatores associados ao uso de medicamen-
tos em adultos, com ênfase nas diferenças entre 
homens e mulheres. Estudo transversal de base 
populacional, com amostra por conglomerados e 
em dois estágios realizado em Campinas em 2008. 
Entre os 2.413 adultos de 20 anos ou mais, a pre-
valência de uso de ao menos um medicamento 
nos três dias que antecederam a pesquisa foi de 
45,4% nos homens e 64,6% nas mulheres. Entre 
os homens, indivíduos com idade acima de 40 
anos, que não realizavam atividade de trabalho, 
ex-fumantes, com presença de doenças crônicas e 
dois ou mais problemas de saúde, e procura por 
algum serviço de saúde nas duas semanas ante-
riores à pesquisa apresentaram maiores prevalên-
cias de uso de medicamentos. Entre as mulheres, 
prevalências mais elevadas de uso foram observa-
das naquelas com idade acima de 40 anos, obesas, 
ex-fumantes, que referiram padrão de sono cur-
to, com uma ou mais doenças crônicas e dois ou 
mais problemas de saúde, e que relataram procura 
de algum serviço de saúde para atendimento nos 
últimos 15 dias. Os achados apontaram algumas 
diferenças nos determinantes do uso de medica-
mentos em relação aos sexos, revelando a maior 
importância dos comportamentos relacionados à 
saúde entre as mulheres.
Palavras-chave  Uso de medicamentos, Prevalên-
cia, População adulta, Inquérito epidemiológico, 
Farmacoepidemiologia
abstract  The objective of this study was to verify 
factors associated with the use of medication by 
adults, with emphasis on the differences between 
men and women. It was a population-based, 
cross-sectional study with cluster sampling con-
ducted in two stages in Campinas in the state of 
São Paulo in 2008. Among the 2,413 individuals 
aged 20 or older, the prevalence of use of at least 
one drug in the three days before the research was 
45.4% (95% CI: 41.3 - 49.4) in men and 64.6% 
(95% CI: 59.8 - 69.2) in women. For adult men 
over 40 years old who were not working, former 
smokers, with one or more chronic diseases, with 
two or more health problems and who sought 
health care or a health professional in the two 
weeks preceding the research showed higher prev-
alence of medication use. Among women, a higher 
prevalence of use was observed in females over 40, 
obese, former smokers, who reported a short sleep 
pattern, with one or more chronic diseases and 
two or more health problems, and who reported 
seeking a health care service or professional in 
the past 15 days. The findings showed some dif-
ferences in the determinants of drug use in rela-
tion to gender, revealing the greater importance of 
health-related behavior among women.
Key words  Medication use, Prevalence, Adult 
population, Epidemiological survey, Pharmaco-
epidemiology
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introduction
The pattern of drug use, including self-medica-
tion, has been widely investigated in national and 
international epidemiological studies, in differ-
ent population segments1-6. 
The factors associated with drug use and 
self-medication, identified in some studies, have 
revealed differences according to subgroups. 
Regarding the consumption in adult popula-
tion, studies have pointed to an increasing use 
of drugs with increasing age, among women2,7-9, 
those with greater purchasing power7-11, among 
the most educated8,12, those that have a higher 
number of chronic diseases2,7,9,11, among others. 
As for self-medication, a study performed in 
Bambuí verified that, for the adult population 
(18 years and older), there is a higher prevalence 
among men, younger subjects (between 18 and 
39 years) and those who reported spending on 
drugs in the last year. Lower prevalence was ob-
served among those who reported one or more 
medical appointments9.
Drug use has been the subject of constant 
attention among health care professionals and 
managers because, while they are necessary for 
the cure or control of diseases, they may also 
represent health risks when not rationally used4. 
Among these risks, we highlight the nonuse of 
the drug in a timely manner, which can lead to 
delays in diagnosis and therapeutics, adverse in-
teractions with other drugs, bacterial resistance, 
drug toxicity and poisoning13,14. 
Considering that there are differences be-
tween men and women in relation to the risk 
of becoming ill, in the perception of signs and 
symptoms, in seeking health services and in 
health care, which vary due to the biological, so-
cio-economic and behavioral factors of the gen-
der15,16, we must pay attention to the singularities 
in the profile of drug use in each of these groups. 
Comparative studies between men and wom-
en point out that, although women report higher 
prevalence of morbidities17, men are more vul-
nerable to severe chronic diseases, which cause 
limitations and are important causes of death16,18. 
Besides that, men seek primary care services in a 
lower proportion than women19, most common-
ly going to emergency rooms, to union clinics 
and to pharmacies for curative care, resulting in 
self-medication20. Consequently, they are more 
subject to procedures that could be avoided if 
preventive measures and the search for health 
care were carried out early21.
Few Brazilian studies have investigated the 
use of drugs considering the male and female 
subgroups separately. Thus, the objective of this 
study was to verify the factors associated with 
drug use in adults, with an emphasis on the dif-
ferences between men and women, in the adult 
population in the city of Campinas, São Paulo, 
Brazil, in 2008.
methods
Population-based, cross-sectional study carried 
out from 2,476 records of non-institutionalized 
adults (20 years and older), residents in the ur-
ban area in the city of Campinas in the period of 
2008 and early 2009. The study used data from 
the health survey of the city of Campinas (ISACa-
mp), performed by the Collaborating Center on 
Health Situation Analysis (CCAS) of the Depart-
ment of Public Health of the School of Medical 
Sciences, University of Campinas (UNICAMP). 
In the survey, the sample was obtained by 
means of probability sampling, by conglomerates 
and in two stages, considering the census sectors 
as primary unit. Thus, in the first stage, 50 census 
sectors were drawn with probability proportion-
al to size, given by the number of households in 
the sector. In the second stage, households were 
selected by systematic randomization applied to 
the households that had been prepared for each 
of the selected sectors. 
The number of persons to compose the 
sample was obtained considering the situation 
corresponding to the maximum variability for 
the frequency of events studied (P = 0.50), 95% 
confidence coefficient in the determination of 
confidence intervals (z = 1.96), sampling error 
between 4 and 5 percentage points and design 
effect equal to 2, amounting to 1,000 individu-
als in each age group, namely: adolescents (10 to 
19 years), adults (20 to 59 years) and elderly (60 
years and more). Sample size was fixed at 1,250 
for 80% response rate. To achieve this sample 
size in each domain, after update in the field of 
the maps of the sectors randomized and prepara-
tion of the list of addresses, 2,150, 700 and 3,900 
households were selected, independently, for 
adolescents, adults and the elderly, respectively. 
In this research, in each household, all residents 
were interviewed in the age group selected for 
that address. The sampling design for the ISA-
Camp 2008 survey has been described in detail by 
Alves22.
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The information was obtained through struc-
tured questionnaire previously tested in pilot 
study and applied in household interviews con-
ducted by interviewers trained and supervised. 
To ensure the quality of the data collected, partial 
second interviews, performed by telephone or in 
person, were conducted on random sample of 
5% of the participants and showed no discrepan-
cy in relation to the original information.
In this study, we used the survey’s data relat-
ing to subjects of 20 years or older and the de-
pendent variable was the use of at least one drug 
in the three days preceding the survey, investigat-
ed by the questions: (1) Have you used any drug 
in the last three days? (2) How many drugs? Which 
ones? 
For the identification of drugs, we request-
ed the presentation of the drug packaging and/
or the medical prescription to minimize errors 
in data annotation by the interviewer. Subse-
quently, the drugs were coded according to the 
Anatomical Therapeutic Chemical Code (ATC-
2009)23. For the identification of the composition 
of drugs, we used the “Dicionário de Especiali-
dades Farmacêuticas” (DEF 2008/2009)24. For the 
drugs whose names the interviewee was unable 
to point out or to provide packing/prescription, 
we assigned an unidentified code; for products 
that were not in the ATC, we created codes to 
identify them, and, for those who did not present 
a specific code in the ATC, we used the code to 
the extent that was possible to identify the group, 
class or therapeutic action. 
In the analysis of the factors associated with 
drug use according to gender, we excluded the 
records relating to the interviews that related 
the use of only contraceptives (n = 63), as this 
is a group of drugs unique to women and whose 
logic differs from the use of other drugs8. The 
following sets of independent variables were se-
lected: 
· Demographic and socio-economic: age 
group, marital status, self-reported color/race, 
education (in years of study), household income 
per capita (in minimum wages), job and number 
of residents in the household.
Health-related behaviors: abusive use of al-
cohol, assessed by the Alcohol Use Disorder 
Identification Test (AUDIT)25, composed of ten 
questions and which identifies the risk of alco-
hol abuse/addiction when its score (0-40 range) 
equals to eight or more26; frequency of alcohol 
consumption categorized into: no consump-
tion, consumption up to once a week and con-
sumption two or more times a week; smoking 
categorized into smoker, former smoker and 
non-smoker; practice of physical activity in the 
context of leisure (active – individuals who prac-
ticed at least 150 minutes per week, distributed, 
at least, in three days; inadequately active – those 
who practiced less than 150 minutes or more 
than 150 minutes, but in less than three days a 
week, and inactive - those who did not dedicate 
any time to leisure physical activity during the 
week); body mass index (BMI = Kg/m2), calcu-
lated based on the weight and height data and 
cut-off points proposed by the World Health 
Organization27 for the adult population: under-
weight (BMI < 18.5 kg/m2), eutrophy (18.5 kg/
m2 ≤ BMI ≤ 24.9 kg/m2);overweight (25.0 kg/m2 
≤ BMI < 30.0 kg/m2) and obese (BMI ≥ 30 kg/
m2); and sleep time (in hours).
· Indicators of health conditions and use of 
health services: health self-assessment, number 
of chronic diseases (considering hypertension, 
diabetes mellitus, cardiovascular disease, tumor/
cancer, rheumatic disease/arthritis/osteoarthritis, 
osteoporosis, asthma/ bronchitis/emphysema, 
tendinopathy/Cumulative Trauma Disorders, 
circulatory problems and others), morbidity in 
the 15 days prior to the survey, common men-
tal disorder (CMD) evaluated based on the Self 
Reporting Questionnaire (SQR-20) with cutoff 
point 7/828, number of health problems (symp-
toms/complaints) (frequent headache/migraine 
disorders, back pain/column problem, hypersen-
sitivity, emotional problem, dizziness/vertigo, in-
somnia, urinary problem), search for health ser-
vice or health care professional for health-related 
issues in the last 15 days, hospitalization in the 
past year and membership in health plan.
In the data analysis, we initially verified the 
association between the various variables and 
drug use according to gender using the Pearson’s 
chi-square testwith a significance level of 5%. 
Then, considering the effect of age on the greater 
drug use2,5,7,8,29, prevalence ratios (PR) were cal-
culated adjusted for age and 95% confidence in-
tervals. The multivariate analysis was performed 
by means of Poisson regression29, for both gen-
ders, obeying the following hierarchical model: 
in the first stage, we included the socio-demo-
graphic characteristics associated with the use 
of drugs. In the second stage, in addition to the 
variables in the first set that maintained signifi-
cance after being adjusted by the other variables 
of the same hierarchical level, we added those re-
lated to health-related behaviors associated with 
use, remaining in the model only those that had 
significance in the adjusting for confounding fac-
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tors belonging to the same hierarchical level and 
at the higher level. In the third stage, we intro-
duced the variables relating to health conditions, 
use of health services and subjective health eval-
uation, given their importance as trigger for the 
search for medical assistance or other alternatives 
to improve/recover the health condition7. There-
fore, we included in the models the variables that 
showed significant association with drug use in 
the simple analysis (p < 0.20) and, in the final 
model, remained those that showed a p < 0.05 
value, adjusted by the variables of higher levels 
and at the same level30.  
Data analyses were performed with the pro-
gram Stata 11.0, whose procedures for analysis 
of population surveys incorporate the various 
aspects of the complex sampling design31.
The research project was approved by the 
Ethics Committee of the University of Campinas.
results
Of the adults interviewed by the survey with an-
swers to the question about drug use in the three 
days preceding the survey, 94.2% (95% CI: 90.8 
- 97.6) of men and 96.9% (95% CI: 95.4 - 98.3) 
of women responded in person to the interview. 
The other interviews were answered by a family 
member or responsible, due to the impossibili-
ty arising from the individual’s health problems. 
The average age of the study population was 41.6 
years (95% CI: 40.3 - 42.9) and 43.7 (95% CI: 
42.4 - 45.0) for men and women, respectively. Re-
garding drug use, 45.4% (95% CI: 41.3 - 49.4) of 
men and 68.0% (95% CI: 63.5 - 72.5) of women 
reported having consumed at least one drug in 
the three days preceding the survey. 
Excluding the specific usage of contracep-
tives, according to the criteria adopted, the prev-
alence of use among women (n = 1,350) was 
64.6% (95% CI: 59.8 - 69.2) and the average 
number of drugs used by the adult population 
investigated in this study (n = 2,413) was 1.5 
(95% CI: 1.3 - 1.6) for women and 0.9 (95% CI: 
0.8 - 1.0) for men.
Table 1 presents the prevalence of drug use, 
by gender, according to socio-demographic 
variables. We observed that, in the simple anal-
ysis, age group, education and job were associ-
ated with drug use for both genders (p < 0.05). 
Marital status was associated only with men and, 
in relation to household income per capita and 
number of people in the household, there was 
an association only for women (p < 0.05). After 
adjusting for age, higher prevalence of drug use 
was verified in women who did not have any jobs 
at the time of the survey, in the limit of statisti-
cal significance (PR = 1.13; 95% CI: 1.00 - 1.29). 
Women showed a higher prevalence of drug use 
than men, except for the age group of 80 years or 
more and among the persons with less education.
With regard to health-related behaviors in the 
male adult population, we observed significant-
ly higher prevalences of drug use among those 
who stopped smoking and those overweight. 
Regarding the women, greater use was verified 
among those who no longer smoke, the obese 
and those who reported a short sleep pattern (up 
to 6 hours). Underweight women showed lower 
prevalence of drug use after adjusting for age (PR 
= 0.66; 95% CI: 0.46-0.95) (Table 2). In assess-
ing the prevalence ratio between the genders, 
we observed that the prevalence of drug use for 
women were not higher than those for men only 
for those who abused alcohol, those insufficiently 
active and in those underweight.
Table 3 presents the prevalence of drug use 
according to health condition and use of health 
services. All variables concerning health condi-
tions were significantly associated with drug use 
in the analysis stratified by gender, as well as the 
search for health service or health care profes-
sional in the past 15 days. Among men, hospital-
ization in the previous year was also associated 
with drug use. The magnitudes of associations 
evaluated by means of prevalence ratios adjusted 
for age, in general, show the greater magnitude of 
associations among men. For the set of variables 
analyzed, women showed higher prevalence of 
drug use, compared to men, for at least one of 
the categories considered (Table 3). 
The hierarchical multiple regression analysis 
results are presented in Tables 4 and 5. For the 
male adult population, among the socio-demo-
graphic variables, age group above 40 years and 
no job remained statistically associated with drug 
use. Of the variables from the set concerning 
health-related behaviors, only former smokers 
had higher prevalence of drug use, after adjust-
ment by the variables of the same set, and by 
those that remained from the set of socio-demo-
graphic characteristics. In the set integrated by 
health conditions, use of health services and sub-
jective health evaluation, the following variables 
remained positively associated: presence of one 
or more chronic disease, presence of two or more 
health problems (symptoms/complaints) and 
search for health service or health care profes-
sional in the past 15 days, when adjusted among 
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each other and for the variables that persisted in 
the previous sets (Table 4). 
In relation to the female population, among 
the socio-demographic variables, only the age 
group older than 40 years remained statistically 
associated with drug use, after adjustment by the 
variables of the same set. For the health-related 
behaviors, former smokers, obese and those who 
reported a short sleeping pattern presented high-
er prevalence, and underweight women showed 
a lower prevalence of drug use, after adjustment 
by the variables of the same set and by the age 
groups. In the set related to health conditions, 
use of health services and subjective health evalu-
ation, the following variables remained positively 
associated: presence of one or more chronic dis-
ease, presence of two or more health problems 
(symptoms/complaints) and search for health 
service or health care professional in the past 15 
days, when adjusted among each other and for 
the variables that were kept in the previous sets 
(Table 5).
Discussion
The prevalence of use of at least one drug in the 
three days preceding the survey was of 45.4% and 
64.6% among adult men and women residing in 
Campinas, respectively. In the research on drug 
use, we should consider the recall period, as the 
prevalence of use depends on the period evaluat-
variables
Socio-economic and 
demographic
Age group
    20 to 39
    40 to 59
    60 to 79
    80 or more
Marital Status
    With partner
    Without partner
Race/color
    White
    Non-white
Education
    0 to 3 years
    4 to 8 years 
    9 or more years 
Household income 
per capita (MW)
    up to 1
    > 1 to  <3
    ≥  3
Job 
    Yes 
    No
# persons in the 
household
    1 to 2 persons
    3 to 4 persons
    5 or more
n = 
1.063
256
193
549
65
754
309
776
284
203
391
469
410
429
224
582
480
431
430
202
Prevalence 
(%) (1)
p = 0.0000*
31.8
53.6
70.7
84.7
p = 0.0035*
50.5
36.4
p = 0.4983*
46.4
42.8
p = 0.0004*
74.0
45.8
41.4
p = 0.4087*
43.3
44.9
50.5
p = 0.0000*
40.5
62.8
p = 0.1654*
51.6
43.7
42.0
table 1. Prevalence of drug use, by gender, according to demographic and socio-economic variables in the adult 
population (20 years or older) of Campinas in 2008. Campinas Health Survey, 2008.
adjusted  Pr 
(95% Ci)** 
1
1.68 (1.29-2.19)
2.22 (1.83-2.69)
2.66 (2.13-2.33)
1.11 (0.89-1.38)
1
1.01 (0.81-1.27)
1
1.15 (0.93-1.42)
0.95 (0.77-1.17)
1
1
1.04 (0.87-1.24)
1.10 (0.89-1.35)
1
1.14 (0.92-1.42)
0.98 (0.81-1.18)
0.96 (0.77-1.20)
1
n: number of individuals in the unweighted sample. * p-value of the chi-square test. ** Prevalence ratio adjusted by age.
adjusted  Pr** 
(2)/(1)
1.63 (1.31-2.01)
1.25 (1.07-1.46)
1.22 (1.14-1.30)
1.05 (0.93-1.17)
1.31 (1.16-1.48)
1.45 (1.16-1.81)
1.34 (1.20-1.50)
1.33 (1.07-1.65)
1.03 (0.86-1.23)
1.43 (1.26-1.62)
1.37 (1.15-1.63)
1.33 (1.16-1.53)
1.43 (1.24-1.65)
1.24 (1.00-1.54)
1.37 (1.16-1.61)
1.19 (1.04-1.36)
1.32 (1.11-1.57)
1.32 (1.12-1.55)
1.39 (1.17-166)
men Women
n = 
1.350
222
227
769
132
647
703
1029
320
401
529
419
586
529
235
385
965
596
493
261
Prevalence 
(%) (2)
p = 0.0000*
51.8
67.1
86.2
88.6
p = 0.8102*
64.3
65.1
p = 0.2103*
66.2
60.4
p = 0.0008*
76.9
68.6
58.1
p = 0.0399*
61.1
70.5
62.3
p = 0.0000*
56.2
73.4
p = 0.0224*
73.2
60.7
62.2
adjusted  Pr 
(95% Ci)** 
1
1.29 (1.13-1.48)
1.66 (1.49-1.86)
1.71 (1.50-1.96)
1.04 (0.93-1.16)
1
1.04 (0.90-1.21)
1
1.01 (0.85-1.21)
1.06 (0.92-1.21)
1
1
1.11 (0.99-1.25)
1.03 (0.90-1.18)
1
1.13 (1.00-1.29)
1.01 (0.86-1.19)
0.94 (0.81-1.09)
1
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ed. The literature does not point an ideal period, 
as this choice depends on what is being recorded 
and the ability of the respondent population to 
recall10; however, regardless of this period, the ac-
curacy of the respondent for drug use decreases 
with increasing age, number of drugs prescribed 
for chronic use and also can vary depending on 
the drug used32. 
The increased use of drugs by women com-
pared to men is consistent with the results ob-
tained in many other epidemiological investiga-
tions2,5-8,12,15,33 and is independent of type of use 
(prescribed or over-the-counter)7. In one of the 
first Brazilian research studies to analyze the pro-
file of population-based drug consumption, held 
in the city of Ribeirão Preto (SP) in the 70s, there 
was already a greater drug usage by women with 
higher rates of morbidity, drug consumption and 
medical appointments, which sharply contrasted 
with the greater male mortality34. There are sever-
al aspects that make women more prone to drug 
use, among them stand out their greater concern 
with health, their performance in the health care 
of their family members, early and more frequent 
search for health services, probably due to greater 
opportunity for care (the incorporation of atten-
tion to women’s health into national health poli-
cies date from the early 20th century)35. 
In addition, the existing specific programs35 
are disseminated and directed to the problems 
that affect women in every stage of life (such as 
in the menstrual period, symptoms and effects of 
estrogen deficiency) and contribute to a greater 
chance of drug use during adulthood, factors 
variables
Health-related behaviors
Abusive use of alcohol /
alcohol addiction
    Yes
    No 
Frequency of consumption 
of alcoholic drinks/week
    No consumption
    Up to once
    Two or more times
Smoking
    Smoker
    Former smoker
    Never smoked
Physical activity during 
leisure
    Active
    Inadeq. Active
    No physical activity
BMI (Kg/m²)
    Underweight (<18.5)
    Eutrophic (18.5 to 24.9)
    Overweight (25 to 29.9)
    Obese ( ≥ 30)
Hours of sleep
    Up to 6 
    7 to 8 
    9 or more
n = 
1.063
128
933
515
323
223
203
257
602
245
153
665
25
486
397
155
174
630
257
Prevalence 
(%) (1)
p = 0.8406*
44.3
45.6
p = 0.0472*
52.3
39.5
42.3
p = 0.0001*
38.2
68.7
42.7
p = 0.0920*
40.5
40.3
49.0
p = 0.0413*
45.5
39.6
50.8
51.3
p = 0.8920*
46.5
44.8
46.7
adjusted  Pr 
(95% Ci)** 
1
1.00 (0.76-1.32)
1
0.85 (0.70-1.05)
0.80 (0.60-1.06)
0.88 (0.69-1.15)
1.27 (1.05-1.54)
1
1
1.11 (0.83-1.50)
1.14 (0.90-1.43)
1.12 (0.64-1.95)
1
1.21 (1.02-1.45)
1.18 (0.94-1.48)
0.96 (0.77-1.20)
1
0.98 (0.80-1.20)
table 2.  Prevalence of drug use, by gender, according to behavioral variables related to health and use of health services in the 
adult population (20 years or older) of Campinas in 2008. Campinas Health Survey, 2008.
n: number of individuals in the unweighted sample. * p-value of the chi-square test. ** Prevalence ratio adjusted by age.
adjusted  Pr** 
(2)/(1)
1.35 (0.89-2.05)
1.34 (1.20-1.49)
1.21 (1.04-1.41)
1.38 (1.13-1.68)
1.70 (1.34-2.16)
1.50 (1.16-1.95)
1.26 (1.04-1.52)
1.34 (1.18-1.51)
1.57 (1.27-1.94)
1.08 (0.80-1.44)
1.28 (1.13-1.46)
0.84 (0.44-1.60)
1.41 (1.19-1.67)
1.28 (1.08-1.52)
1.41 (1.19-1.67)
1.60 (1.22-2.08)
1.26 (1.11-1.43)
1.37 (1.12-1.69)
men Women
n = 
1.350
18
1329
1022
283
42
157
154
1037
246
139
965
59
533
448
310
261
782
292
Prevalence 
(%) (2)
p = 0.2824*
53.5
64.9
p = 0.3130*
66.2
59.4
70.4
p = 0.0051*
61.5
83.1
62.5
p = 0.1399*
71.7
57.8
63.8
p = 0.0000*
37.7
58.5
69.8
77.1
p = 0.0021*
78.9
60.7
65.4
adjusted  Pr 
(95% Ci)** 
1
1.08 (0.74-1.57)
1
0.94 (0.79-1.12)
1.11 (0.86-1.42)
1.00 (0.85-1.17)
1.29 (1.12-1.49)
1
1
0.81 (0.64-1.02)
0.92 (0.79-1.06)
0.66 (0.46-0.95)
1
1.12 (0.98-1.28)
1.23 (1.09-1.38)
1.22 (1.09-1.37)
1
1.08 (0.92-1.28)
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that may partially explain the greater use in this 
group. In the study conducted by Pedro et al.36 in 
Campinas about the search for medical services 
among menopausal women revealed that, for the 
major complaints (menstrual irregularity, cli-
macteric symptoms and urogenital symptoms), 
all women were medicated and almost all fol-
lowed the prescription indicated. 
Pelicioni and César33, based on data from a 
home health survey carried out in four areas of 
the State of São Paulo (ISA-SP), observed in-
creased drug use in the higher age groups and a 
higher prevalence among women compared to 
men, considering the same period used in the 
present study, which was also verified by Cos-
ta et al.2 with health survey data in the State of 
São Paulo (ISA-SP) and by Perrone et al.37 on 
the analysis of ISA-SP data disaggregated for the 
city of Campinas. This trend, also observed in 
the present study, is consistent in the literature 
and, possibly, is due to the higher prevalence 
of co-morbidities with advancing age38. In this 
study, we could observe that the increasing drug 
use according to age groups occurs differently in 
variables
Health conditions
Health self-assessment
    Excellent/Very good
    Good
    Bad/Very bad
# of chronic diseases
    0
    1
    2 
    3
    4 or more
# of health problems
    0
    1
    2 
    3
    4 or more
Common Mental Disorder
    Yes
    No
Use of health services
Search for health service 
or health care professional 
in the past 15 days
    Yes 
    No 
Hospitalization in the 
previous year
    Yes 
    No 
Health plan
    Yes 
    No 
table 3. Prevalence of drug use, by gender, according to the variables of health conditions and use of health services in the 
adult population (20 years or older) of Campinas in 2008. Campinas Health Survey, 2008.
n: number of individuals in the unweighted sample. * p-value of the chi-square test. ** Prevalence ratio adjusted by age.
men Women
n = 
1.063
362
601
100
469
269
168
92
56
409
327
190
94
43
85
977
198
865
124
939
458
605
Prevalence 
(%) (1)
p = 0.0000* 
36.3
48.4
83.1
p = 0.0000*
28.2
65.9
87.0
80.2
96.7
p = 0.0000*
34.4
46.8
52.2
68.7
85.8
p = 0.0030*
76.2
43.5
p = 0.0000*
75.8
40.0
p = 0.0223*
59.7
44.2
p = 0.4897*
47.2
44.1
adjusted  Pr 
(95% Ci)  
1
1.19 (0.98-1.45)
1.84 (1.47-2.30)
1
2.12 (1.73-2.61)
2.53 (2.04-3.14)
2.13 (1.63-2.79)
2.47 (2.02-3.02)
1
1.29 (1.07-1.55)
1.46 (1.16-1.84)
1.78 (1.34-2.37)
2.11 (1.63-2.73)
1.55 (1.19-2.01)
1
1.72 (1.45-2.04)
1
1.12 (0.92-1.38)
1
1.05 (0.86-1.27)
1
adjusted  Pr** 
(2)/(1)
1.38 (1.12-1.70)
1.32 (1.14-1.52)
1.12 (0.92-1.36)
1.51 (1.20-1.90)
1.07 (0.93-1.23)
1.07 (0.97-1.18)
1.23 (0.97-1.55)
1.02 (0.97-1.08)
1.21 (0.91-1.62)
1.15 (0.94-1.41)
1.30 (1.04-1.61)
1.18 (0.90-1.54)
1.04 (0.85-1.27)
1.15 (0.92-1.42)
1.32 (1.18-1.47)
1.07 (0.90-1.26)
1.37 (1.21-1.57)
1.24 (0.97-1.58)
1.34 (1.20-1.51)
1.36 (1.16-1.60)
1.32 (1.15-1.51)
n = 
1.350
371
829
150
369
300
254
193
211
307
364
282
199
198
235
1114
348
1002
172
1178
638
710
Prevalence 
(%) (2)
p = 0.0000*
52.8
67.5
93.6
p = 0.0000* 
42.7
70.8
93.2
95.2
99.1
p = 0.0000* 
43.0
57.9
72.0
81.4
89.8
p = 0.0000* 
89.2
60.5
p = 0.0001*
81.7
59.3
p = 0.1815*
71.7
63.7
p = 0.1145*
68.4
61.4
adjusted  Pr 
(95% Ci)* 
1
1.20 (1.00-1.44)
1.59 (1.33-1.90)
1
1.62 (1.35-1.94)
2.07 (1.73-2.48)
2.10 (1.72-2.55)
2.15 (1.80-2.56)
1
1.28 (0.96-1.70)
1.59 (1.19-2.13)
1.77 (1.33-2.37)
1.91 (1.50-2.43)
1.36 (1.24-1.49)
1
1.34 (1.18-1.52)
1
1.09 (0.94-1.28)
1
1.09 (0.95-1.24)
1
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relation to gender and that only for the elderly 
there were no differences in the prevalence ratio 
according to gender. 
The average number of drugs consumed by 
the adult population of Campinas was similar 
to that observed for studies performed with the 
same period recorded2,37.
Marital status and education among men, as 
well as education, household income per capi-
ta, job and number of people in the household 
among women, who had association with drug 
use in the simple analysis, lost their significance 
after the adjusted analysis, as verified in oth-
er studies6,8. Studies indicate the importance of 
the socio-economic level and, specifically, the 
monthly family income as determinants of drug 
consumption5-8, which was not verified in this 
study for the variables analyzed. 
Among men, there was a higher prevalence 
of drug use in those who did not have a job at 
the time of the research. In a study performed in 
Catalonia with adult population of 25 to 64 years, 
there was higher drug consumption among re-
tired men, but not among the women6. More-
over, in relation to job, some studies have found 
higher prevalence of drug use and self-medi-
cation among the unemployed, students and 
housewives7,39,40. In this study, drug use was not 
evaluated according to prescription, but when 
comparing genders, drug consumption without 
medical or dental indication showed no statisti-
cal difference (data not presented).
variable
Age groups (years)
     20 to 39
     40 to 59
     60 to 79
     80 or more
Job
     Yes
     No
Smoking
     Never smoked
     Smoker
     Former smoker
# of chronic diseases
     0
     1
     2
     3
     4 or more
# of health problems
     0
     1
     2
     3
     4 or more
Search for health service or 
health professional in the 
past 15 days
     No
 Yes
first step 
adjusted  Pr* (95% Ci)
1
1.68 (1.29 - 2.18)
1.95 (1.57 - 2.44)
2.18 (1.67 - 2.85)
1
1.28 (1.05 - 1.57)
table 4.  Final results of the hierarchical regression analysis of factors associated with drug use in the male adult 
population (20 years or older). Campinas, São Paulo. Campinas Health Survey, 2008.
*Adjusted by the socio-demographic variables. ** Adjusted by the socio-demographic and health-related behavior variables. 
*** Adjusted by the socio-demographic, health-related behavior, health condition, use of services, and health self-assessment 
variables. PR: Prevalence ratio adjusted by means of Poisson multiple regression.
third step
 adjusted  Pr*** (95% Ci)
-
-
-
1
1.98 (1.63 - 2.40)
2.34 (1.93 - 2.84)
1.99 (1.45 - 2.73)
2.10 (1.68 - 2.63)
1
1.25 (1.01 - 1.55)
1.40 (1.13 - 1.73)
1.35 (1.03 - 1.75)
1.57 (1.26 - 1.93)
1
1.51 (1.26 - 1.81)
second step 
adjusted  Pr** (95% Ci)
-
-
1
0.85 (0.66 - 1.09)
1.31 (1.09 - 1.58)
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With regard to health-related behaviors, we 
observed higher prevalence of drug use among 
men and women who stopped smoking. The 
same trend was observed for point estimates 
in the study of Bardel, et al.38, without, howev-
er, achieving statistical significance. The higher 
prevalence of use could be partially explained 
as these persons constitute a group with worse 
health conditions, resulting from the effect of 
smoke exposure, which may have even motivated 
the abandonment of smoking8. Evidence shows 
smoking as part of the chain of causality of al-
most 50 different diseases, including cardiovas-
cular diseases, cancers and respiratory diseases41.
Also among women, underweight was in-
versely associated with use, and obesity and short 
sleep pattern had higher prevalence of drug use. 
Bardel, et al.38, in a study with Swedish women 
of 35 to 65 years in Sweden, and Bertoldi, et al.8 
verified that prevalences of drug use were sig-
variable
Age groups (years)
    20 to 39 
    40 to 59
    60 to 79
    80 or more
Smoking
    Never smoked
    Smoker
    Former smoker
BMI (Kg/m²)
    Underweight (<18.5)
    Eutrophic (18.5 to 24.9)
    Overweight (25 to 29.9)
    Obese ( ≥ 30)
Hours of sleep
    Up to 6 
    7 to 8 
    9 or more
# of chronic diseases
     0
     1
     2
     3
     4 or more
# of health problems
     0
     1
     2
     3
     4 or more
Search for health service or 
health professional in the 
past 15 days
     No
     Yes
first step 
adjusted  Pr* (95% Ci)
1
1.29 (1.12 - 1.48)
1.65 (1.48 - 1.84)
1.69 (1.47 - 1.94)
table 5.  Final results of the hierarchical regression analysis of factors associated with drug use in the female 
adult population (20 years or older). Campinas, São Paulo. Campinas Health Survey, 2008.
*Adjusted by the socio-demographic variables. ** Adjusted by the socio-demographic and health-related behavior variables. 
*** Adjusted by the socio-demographic, health-related behavior, health condition, use of services, and health self-assessment 
variables. PR: Prevalence ratio adjusted by means of Poisson multiple regression.
third step
 adjusted  Pr*** (95% Ci)
-
-
-
-
1
1.48 (1.24 - 1.78)
1.68 (1.39 - 2.05)
1.70 (1.39 - 2.09)
1.67 (1.39 - 2.02)
1
1.23 (0.87 - 1.72)
1.55 (1.14 - 2.12)
1.53 (1.08 - 2.17)
1.65 (1.21 - 2.25)
1
1.15 (1.02 - 1.31)
second step 
adjusted  Pr** (95% Ci)
-
1
1.00 (0.86 - 1.18)
1.26 (1.10 - 1.45)
0.63 (0.43 - 0.92)
1
1.11 (0.96 - 1.27)
1.20 (1.05 - 1.37)
1.19 (1.06 - 1.35)
1
1.08 (0.92 - 1.26)
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nificantly higher among the obese, as verified 
in the present study; however, in both studies, 
the category underweight (BMI < 18.5) was not 
considered. The association between obesity and 
chronic morbidities, such as diabetes mellitus, 
hypertension and cardiovascular diseases (data 
not shown), consistent with health surveys con-
ducted elsewhere42,43, may partially explain this 
finding. In this study, among women who had 
the desire to lose weight, the use of medications 
for weight loss was rarely mentioned. 
In this study, sleep duration equal to less than 
6 hours was positively associated with drug use 
among women. Epidemiological studies have ob-
served that the pattern of short or long sleep is 
associated with increased morbidity44-46. Changes 
in sleep duration can be peculiar symptoms of 
diseases, but the use of medicines can also change 
the sleep pattern. In this sense, it is not possible 
to clarify the cause-and-effect relationship of this 
association in a cross-sectional study, due to the 
possibility of reverse causality, which highlights 
the need for studies to find, from the pharma-
cological point of view, what is the relationship 
between the specific drugs used and their associ-
ation with the sleep pattern in more detail.
In relation to health conditions and the use 
of health services, for the presence of chronic dis-
ease, which is the main determinant of drug use 
in both genders2,7,9,11, the magnitudes of associa-
tions were higher among men. 
In this study, health problems (symptoms/
complaints) often referred to by the adult pop-
ulation were considered in the analysis with the 
objective of scaling their importance and mag-
nitude given the indicators traditionally used in 
studies on drug use, and, for both men and wom-
en, they were significantly associated with drug 
use. The health problems mentioned by the pop-
ulation determine the drug use for a real need 
and the symbolic function of the drugs. Also, in 
addition to cultural and behavioral factors that 
partially explain the use, the need motivated by 
advertisements promoted by the pharmaceuti-
cal industry and primarily related to non-pre-
scription drugs heavily contribute to the use47. 
We stress that when handling these problems/
complaints - which may harbor other more se-
rious health problems that require specific care 
and/or treatment - non-prescription drugs are 
often used (self-medication) and the drugs com-
monly used in these cases belong to the group of 
analgesics, antipyretics and NSAIDs (data not 
presented). Information based on scientific evi-
dence and knowledge in pharmacology enables 
the pharmacist to take actions that can improve 
the practice of self-medication subsidizing the 
proper use of these drugs39,48. In this sense, the 
pharmacist has the important role of providing 
sufficient information to ensure the responsible 
self-medication.
The search for health services or a health care 
professional in the 15 days before the survey was 
significantly associated with drug use. Studies 
indicate a high proportion of drug prescription 
for respondents who seek health care5,7,15,49. The 
medicalization of society is a complex phenome-
non related to socio-cultural, political and scien-
tific transformations based on the incorporation 
of standards of conduct of biomedical origin, 
on the general culture, and on the redefinition 
of human experiences associated with medical 
problems47. Excess drug use cannot be attribut-
ed solely to medical action, but to the reduction 
of sickness caused by a problem in the “human 
machine”, disregarding the social, behavioral, 
cultural and psychological determinants related 
to the health-disease process47,50. However, the 
medical care, commonly classified by the user as 
quick, superficial and impersonal, often has been 
summarized to the prescription of the best drug 
suited to the symptoms7,39. 
 Among the limitations of this study, the 
three-day recall period may underestimate the 
prevalence of use, since, the longer is the period 
(15 or 30 days), the greater will be the likelihood 
of an eventual use of a drug. The continuous-use 
medication can also be counted in any length of 
period. However, we must consider that a longer 
period could also generate a memory bias in rela-
tion to drugs of sporadic use, commonly used by 
the adult population and without medical pre-
scription, promoting an understating especially 
about the pharmaceuticals used for minor ill-
nesses1,2,8. We should also consider that this study 
used data from a comprehensive health survey, 
which may lead to different results than the ones 
obtained from a specific survey on this theme. 
Even though the period remembered when 
obtaining information is an important method-
ological aspect in comparative approaches, we 
observed a high prevalence of drug use in the 
adult population of Campinas, which is also in-
fluenced by the availability and quality of medical 
care services, among other factors not assessed in 
this study. 
The differences observed in the prevalence 
and magnitude of drug use reflect the specific-
ities of the subgroups evaluated with regard to 
socio-demographic characteristics, health-relat-
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ed behaviors, health status and service use. In 
this study, the findings showed some differences 
in determinants of drug use in relation to gen-
der, revealing the greater importance of obesity 
and the short sleep pattern among women. They 
also revealed that, despite the higher prevalence 
of drug use among women for almost all vari-
ables considered, the growing trend of drug use 
according to age groups and an increase in the 
number of chronic diseases was more markedly 
noted among men. This allowed us to identify 
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the importance of health problems/complaints 
often referred to by the population, regarding the 
use of drugs and health-related behavior, espe-
cially among adult women in Campinas. 
Studies that include the identification of 
drugs that are being used by specific population 
groups may contribute to the knowledge about 
the profile of medical prescription and self-med-
ication, as well as a more detailed investigation 
with regard to the appropriateness of use, given 
the morbidities.
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